Videos
Reaching Deep Remissions with a New Therapy for Multiple Myeloma Patients
Roswell Park is spearheading efforts to study innovative CAR T-cell therapies in addition to offering traditional treatment approaches.
Warning Signs of Hematologic Malignancies in the Primary Care Setting
Eunice Wang, MD, Chief of the Leukemia Service at Roswell Park Comprehensive Cancer Center, offers guidance on what red flags may indicate a hematologic cancer in your patients to help you identify these complex and often difficult-to-treat ...
Benefits of Combining Beta-Blocker and Checkpoint Inhibitor
The same biochemical triggers that spur a “fight or flight” response when we encounter threats may help tumor cells to thrive.
Mapping the Battlefield: Imaging of Multiple Myeloma
Jens Hillengass, MD, shares a history of myeloma imaging, the variety of sophisticated imaging techniques available, and shares several examples to help determine diagnosis.
Plasma Cell Disorders Meeting 2019
Knowing and Fighting the Enemy! This is a clinically-oriented lecture with the intention of allowing oncologists and other cancer health care providers learn more about the biology and diagnostics of Plasma Cell Disorders, and the latest ...
In this lecture Maximilian Merz, MD, looks at the criteria of diagnostics for myeloma disease as well as available treatments.
Caring for the Wounded: Treatment of Myeloma Bone Disease 2
Hillary Jacobson, DPT, shares the importance of exercise in reducing fatigue in patients diagnosed with cancer.
Finding New Weapons: Novel Treatment Approaches in Myeloma
Kelvin Lee, MD, gives a “philosophical talk” regarding novel treatment approaches in myeloma. This lecture helps illustrate the way doctors think about drugs and treatments for treating myeloma.
Caring for the Wounded: Treatment of Myeloma Bone Disease 1
Ryan Hare, PharmD, discusses the treatment of Myeloma Bone Disease. This lecture will review the myeloma bone microenvironment, discuss bone preservation benefits of treatments, describe aniti-myeloma properties, and highlight medication ...
News
Roswell Park Expert to Present on Effectiveness of New Combination for Acute Myeloid Leukemia
Results on FLT3 inhibitor crenolanib in combination with chemotherapy to be presented in talk at ASCO 2022
From ASCO 2022: Brentuximab Vedotin and Chemotherapy an Effective Treatment for Hodgkin Lymphoma
Children’s Oncology Group study shows benefit for children and adolescents with high-risk HL treated with the combination
A multidisciplinary research team led by Song Yao, PhD, Professor of Oncology in the Department of Cancer Prevention and Control at Roswell Park Comprehensive Cancer Center and Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s ...
CME
This site is intended for healthcare professionals